London, Canada

Calvin R Stiller

This inventor holds 1 USPTO granted patent. Top assignee: London Health Sciences Centre. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Calvin R Stiller. Retrieved from https://idiyas.com/inventor/calvin-r-stiller

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Calvin R. Stiller

Introduction

Calvin R. Stiller is a notable inventor based in London, Canada. He has made significant contributions to the field of immunology through his innovative research and patents. His work focuses on methods for controlling the immune response in mammals, particularly in relation to glutamic acid decarboxylase.

Latest Patents

Calvin R. Stiller holds a patent for "Methods and products for controlling the immune response of a mammal to glutamic acid decarboxylase." This patent describes a method for expressing a mammalian antigen in transformed plants. The goal is to provide a source of plant material for oral or enteral administration to a mammal, ultimately producing tolerance to the antigen. He has 1 patent to his name.

Career Highlights

Stiller is affiliated with the London Health Sciences Centre, where he continues to advance his research in immunology. His work has implications for therapeutic approaches in treating various immune-related conditions.

Collaborations

Calvin has collaborated with esteemed colleagues such as Anthony Jevnikar and Shengwu Ma, contributing to a rich environment of innovation and research.

Conclusion

Calvin R. Stiller's contributions to immunology through his patent and work at the London Health Sciences Centre highlight his role as an influential inventor in the field. His innovative methods pave the way for future advancements in immune response management.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…